Schedule of Cash, Cash Equivalents and Short-term Investments |
The fair value of cash and cash equivalents, restricted cash and investments held are as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of June 30, 2025 | | | Amortized Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Estimated Fair Value | | | (in thousands) | Cash and cash equivalents | | $ | 21,364 | | | $ | — | | | $ | — | | | $ | 21,364 | | Restricted cash | | 29,000 | | | — | | | — | | | 29,000 | | Total cash and cash equivalents and restricted cash | | $ | 50,364 | | | $ | — | | | $ | — | | | $ | 50,364 | | Securities maturing within one year: | | | | | | | | | U.S. treasury securities | | 94,853 | | | 5 | | | (12) | | | 94,846 | | Corporate debt securities | | 22,804 | | | 4 | | | (11) | | | 22,797 | | Total short-term investments | | $ | 117,657 | | | $ | 9 | | | $ | (23) | | | $ | 117,643 | | Total cash and cash equivalents, restricted cash and short-term investments | | $ | 168,021 | | | $ | 9 | | | $ | (23) | | | $ | 168,007 | | | | | | | | | | | | | As of December 31, 2024 | | | Amortized Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Estimated Fair Value | | | | | (in thousands) | | | Cash and cash equivalents | | $ | 66,656 | | | $ | — | | | $ | — | | | $ | 66,656 | | Restricted cash | | — | | | — | | | — | | | — | | Total cash and cash equivalents and restricted cash | | $ | 66,656 | | | $ | — | | | $ | — | | | $ | 66,656 | | Securities maturing within one year: | | | | | | | | | U.S. treasury securities | | 127,884 | | | 106 | | | — | | | 127,990 | | Corporate debt securities | | 43,299 | | | 30 | | | (18) | | | 43,311 | | Total short-term investments | | $ | 171,183 | | | $ | 136 | | | $ | (18) | | | $ | 171,301 | | Total cash and cash equivalents, restricted cash and short-term investments | | $ | 237,839 | | | $ | 136 | | | $ | (18) | | | $ | 237,957 | |
|